Table 1. Patient information.

Sample ID code	Age (years, at plasma collection)	Gender	Health Condition	Treatment
FH17-07	64	Female	Healthy individual	Untreated
FH17-08	77	Male	Healthy individual	Untreated
FH17-09	68	Female	Healthy individual	Untreated
FH17-10	65	Female	Healthy individual	Untreated
FH17-11	72	Female	Healthy individual	Untreated
FH17-12	72	Female	Healthy individual	Untreated
FH17-16	76	Female	Healthy individual	Untreated
FH17-18	68	Female	Healthy individual	Untreated
FH16-24	77	Male	Idiopathic PD patient	Statins
FH16-25	65	Male	Idiopathic PD patient	Statins + Levodopa
FH16-26	63	Male	Idiopathic PD patient	Levodopa
FH16-31	81	Female	Idiopathic PD patient	Levodopa
FH16-32	85	Male	Idiopathic PD patient	Levodopa
FH16-34	71	Male	Idiopathic PD patient	Levodopa
FH16-35	71	Male	Idiopathic PD patient	Statins
FH16-38	48	Male	Idiopathic PD patient	Levodopa
FH13-11	84	Female	p.G2019S PD patient	Levodopa
FH13-13	73	Female	p.G2019S PD patient	Levodopa
FH16-39	81	Male	p.G2019S PD patient	Levodopa
FH16-43	77	Female	p.G2019S PD patient	Statins + Levodopa
FH16-44	79	Female	p.G2019S PD patient	Statins + Levodopa
FH17-03	78	Female	p.G2019S PD patient	Levodopa
FH17-01	67	Female	p.G2019S PD patient	Statins + Levodopa
FH16-45	73	Female	p.G2019S PD patient	Levodopa
FH16-27	72	Male	p.R1441G PD patient	Levodopa
FH16-28	68	Male	p.R1441G PD patient	Levodopa
FH17-15	67	Male	p.R1441G PD patient	Statins + Levodopa
FH13-11	88	Female	p.R1441G PD patient	Statins + Levodopa
FH13-13	77	Female	p.R1441G PD patient	Untreated
FH09-78	67	Male	p.R1441G PD patient	Statins + Levodopa
FH10-11	54	Male	p.R1441G PD patient	Levodopa
FH10-12	59	Female	p.R1441G PD patient	Levodopa

Abbreviations: PD, Parkinson’s disease.